Bottom line
HFSFX vs FIWCX: the short answer
HFSFX (Hartford Schroders International Contrarian Value Fund) and FIWCX (Fidelity SAI International Value Index Fund) are both mutual funds.
But FIWCX is far broader, holding 204 positions to 52 for HFSFX, so beyond the top names it adds exposure HFSFX doesn't have.
FIWCX is cheaper at 0.16% vs 0.7% — a difference of $54 a year per $10,000 invested.
Updated Nov 19, 2026
HFSFX vs FIWCX side by side
| HFSFX | FIWCX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Hartford | Fidelity |
| Category | International Stock | International Stock |
| Expense ratio | 0.7% | 0.16% |
| Annual cost per $10k | $70 | $16 |
| 10-yr cost on $10k (prospectus) | $1,024 | $205 |
| Max front load | 0% | — |
| 12b-1 fee | 0% | 0% |
| 1-yr return | — | +5.0% |
| 5-yr return (annualized) | — | +5.1% |
| 10-yr return (annualized) | — | — |
| Best quarter | — | +22.0% |
| Worst quarter | — | −29.6% |
| Net assets (fund) | $246.4M | $14.2B |
| Number of holdings | 52 | 204 |
| Portfolio turnover | 38% | 58% |
| Returns as of | — | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
2 of HFSFX's top 25 holdings also appear in FIWCX's top 25.
| Holding | HFSFX | FIWCX |
|---|---|---|
| Gsk Plc | 2.63% | 2.01% |
| Barclays PLC | 2.04% | 1.88% |
Source: SEC Form N-PORT
HFSFX top 10
- State Street Global Advisors — 2.77%
- Randstad NV — 2.71%
- ABN AMRO Bank NV — 2.70%
- Societe Generale SA — 2.65%
- Gsk Plc — 2.63%
- Sanofi SA — 2.61%
- Evonik Industries AG — 2.49%
- Henkel AG & Co KGaA — 2.38%
- Reckitt Benckiser Group PLC — 2.26%
- Dentsu Group Inc — 2.17%
FIWCX top 10
- Toyota Motor Corp — 2.80%
- Bnp Paribas — 2.53%
- Novo-nordisk As — 2.41%
- Shell Plc — 2.32%
- Totalenergies Se — 2.23%
- Deutsche Telekom Ag — 2.10%
- Rio Tinto Plc — 2.06%
- Mitsubishi Corp — 2.05%
- Gsk Plc — 2.01%
- Barclays Plc — 1.88%
FAQ
What is the difference between HFSFX and FIWCX?
Which is cheaper, HFSFX or FIWCX?
Should I own both HFSFX and FIWCX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.